T. Rowe Price Associates’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $148K | Sell |
69,077
-26,609
| -28% | -$57K | ﹤0.01% | 2810 |
|
|
2025
Q1 | $111K | Buy |
95,686
+54,400
| +132% | +$63.1K | ﹤0.01% | 2797 |
|
|
2024
Q4 | $91K | Sell |
41,286
-13,616
| -25% | -$30K | ﹤0.01% | 2839 |
|
|
2024
Q3 | $120K | Buy |
54,902
+2,169
| +4% | +$4.74K | ﹤0.01% | 2785 |
|
|
2024
Q2 | $122K | Buy |
52,733
+4,706
| +10% | +$10.9K | ﹤0.01% | 2718 |
|
|
2024
Q1 | $265K | Sell |
48,027
-155,291
| -76% | -$857K | ﹤0.01% | 2488 |
|
|
2023
Q4 | $503K | Sell |
203,318
-3,623,237
| -95% | -$8.96M | ﹤0.01% | 2164 |
|
|
2023
Q3 | $133M | Sell |
3,826,555
-122,738
| -3% | -$4.26M | 0.02% | 458 |
|
|
2023
Q2 | $130M | Buy |
3,949,293
+1,263,761
| +47% | +$41.5M | 0.02% | 477 |
|
|
2023
Q1 | $90M | Buy |
2,685,532
+879,958
| +49% | +$29.5M | 0.01% | 533 |
|
|
2022
Q4 | $59.2M | Buy |
1,805,574
+1,120,232
| +163% | +$36.7M | 0.01% | 626 |
|
|
2022
Q3 | $23.9M | Buy |
+685,342
| New | +$23.9M | ﹤0.01% | 854 |
|